Garlic, arjuna and guggul: traditional use and where it stops

These three appear in almost every Ayurvedic cardiovascular product sold in India. Each has long traditional use. Each has a different reason its modern evidence fails to support what the pack implies.

That variety is the useful part. Garlic is a case of early promise not surviving better trials. Arjuna is a case of too little human evidence to say. Guggul is a case of a traditional use that modern trials actively failed to confirm, and of a real safety problem.

We manufacture in this category. That is why this is written as a limits piece.

This is information, not medical advice. Cardiovascular disease is diagnosed and treated medically. Never stop or delay prescribed treatment, and tell your doctor about every herbal product you take.

Garlic (Allium sativum, lahsun)

Traditional use

Long and near-universal, in Ayurveda (rasona), in Unani, and in traditional practice across Europe and Asia. Used for vata and kapha conditions, for lipids, and as a general tonic.

And in Ayurveda a specific point of interest: garlic is rasona, and it is classically excluded from certain diets as a rajasic food, which is a cultural constraint worth knowing if you are formulating for the Indian market, because a substantial number of customers will not take it.

The chemistry

The active chemistry is unstable and that is the whole formulation problem.

Intact garlic contains alliin, which is odourless. When garlic is crushed, the enzyme alliinase converts it to allicin, the pungent compound usually credited with the activity.

And allicin is unstable. It degrades within hours into a range of sulphur compounds. So:

• Raw crushed garlic generates allicin, briefly
• Cooking inactivates alliinase, so cooked garlic produces little allicin
• Garlic powder tablets are standardised to “allicin yield” potential, which depends on enteric coating surviving stomach acid
• Aged garlic extract contains no allicin at all, its chemistry is S-allylcysteine, which is different
• Garlic oil is different again

This matters more than it sounds: the trials used different preparations, so “garlic” in one study is not the same substance as “garlic” in another. Some of the inconsistency in the literature is this, and not biology.

What the evidence shows

This is a textbook case of early promise narrowing under scrutiny.

Early, smaller trials and meta-analyses suggested meaningful cholesterol reductions.

Then better-designed trials, longer, properly blinded, with verified preparations, found little or no effect on LDL. A well-known rigorous trial comparing raw garlic, powdered supplement and aged extract against placebo over six months found no significant effect on LDL for any of them.

Pooled analyses have since generally concluded the lipid effect is small at best and probably not clinically meaningful.

Blood pressure is more favourable: several analyses report a modest reduction in blood pressure, more evident in people who are hypertensive at baseline. The effect is small, not comparable to an antihypertensive medicine, but it is the most defensible finding for garlic.

Platelet aggregation: garlic does inhibit it. This is a genuine effect, and it is a safety issue rather than a selling point, see below.

Honest summary: a reasonable food, a modest blood pressure effect, and no meaningful cholesterol-lowering in good trials.

Safety

Bleeding risk. Garlic inhibits platelet aggregation, and high-dose supplements with warfarin, clopidogrel, aspirin or DOACs compound that.

Stop high-dose garlic supplements before surgery, commonly advised about a week or two ahead. Tell your surgeon and anaesthetist.

It induces drug metabolism, notably reducing levels of some HIV protease inhibitors and saquinavir, which is clinically significant.

Gastrointestinal upset and reflux, and odour, which drives non-adherence.

Arjuna (Terminalia arjuna)

Traditional use

Classically hridya, cardiotonic, and it is the principal cardiovascular herb of the Ayurvedic materia medica. The stem bark is used.

Classical indications include chest pain, palpitations and general cardiac weakness, and it appears in Arjunarishta (Parthadyarishta) and Arjuna Ksheerapaka, a classical milk decoction.

And a point in its favour: unlike many herbs marketed for the heart, arjuna’s traditional indication actually is cardiac. The positioning is not invented.

The chemistry

Tannins, triterpenoid saponins (arjunolic acid, arjungenin), flavonoids and glycosides.

What the evidence shows

And here the honest answer is: we do not know enough.

Laboratory and animal work reports antioxidant, anti-inflammatory, inotropic (contractility-increasing), antiplatelet and lipid-lowering effects.

Human studies exist, small trials in stable angina, heart failure and post-myocardial-infarction have reported improvements in symptoms and some measures. And they are small, often unblinded, mostly single-centre, and several are decades old with methodology that would not pass review now.

There is no adequately powered, well-designed randomised trial of arjuna for any cardiac outcome.

So: the classical rationale is the most coherent of the three, the preclinical pharmacology is interesting, and the human evidence is insufficient to support a claim. That is an honest position and it is not a satisfying one.

Safety

Generally reasonably tolerated in traditional use.

Cautions: possible interaction with antiplatelet and anticoagulant medicines; reported thyroid effects in animal work; theoretical additive effect with cardiac and antihypertensive drugs, which matters because the people taking arjuna are usually on those.

Avoid in pregnancy and lactation for want of data.

And a sourcing point: Terminalia arjuna bark is subject to adulteration with other Terminalia species. Botanical identity testing is not a formality here.

Guggul (Commiphora wightii / mukul)

Traditional use

One of the most important classical formulations exists around it, Guggulu preparations, with Triphala Guggulu, Yograj Guggulu, Kaishore Guggulu and Medohar Guggulu among the best known.

Classically used for medoroga (disorders of fat tissue), joint disease, and kapha conditions. The lipid indication is genuinely traditional, not a modern graft.

What the evidence shows

And this is the most instructive of the three, because it is a case where modern trials actively contradicted the expectation.

Early Indian studies in the 1980s and 1990s reported significant lipid reductions with guggulipid, and this generated real scientific interest internationally.

Then a well-conducted randomised placebo-controlled trial in the United States, published in a major journal, found no reduction in LDL, and, notably, LDL rose slightly in the guggul groups. A proportion of participants developed a hypersensitivity rash.

Subsequent reviews have described the evidence as inconsistent and insufficient.

So the honest statement is uncomfortable and necessary: guggul’s lipid-lowering claim is not supported, and the best trial pointed the other way.

There is more plausible preclinical work on its anti-inflammatory activity, which aligns better with the classical joint-disease use than with the lipid one, and that may be where its real interest lies.

Safety, and this is the important part

Guggul has the most significant interaction profile of the three.

Thyroid. Guggulsterones affect thyroid function, animal work shows stimulation, and the clinical direction in humans is not well characterised. Caution in any thyroid disorder and in anyone on thyroid replacement.

Drug metabolism. Guggul induces cytochrome P450 enzymes and has been shown to reduce blood levels of propranolol and diltiazem, two cardiovascular drugs. A patient taking guggul alongside their cardiac medicine may be getting less of the medicine. This is a real, documented, under-communicated problem.

Bleeding risk, additive with anticoagulants and antiplatelets.

Pregnancy, contraindicated. It has traditional emmenagogue use and is on standard avoid lists.

Hypersensitivity rash, as seen in trials.

Gastrointestinal upset, and headache.

And conservation: Commiphora wightii is assessed as critically endangered. Wild harvesting pressure is severe. Sourcing is an ethical question here, not only a quality one, and a manufacturer should be able to say where their guggul comes from and whether it is cultivated.

Side by side

	Garlic	Arjuna	Guggul
Classical standing	Broad traditional use	Hridya, the cardiac herb	Guggulu formulations; medoroga
Why the evidence disappoints	Good trials found no lipid effect	Too little good human data	Best trial contradicted the claim
Most defensible finding	Modest blood pressure reduction	Preclinical inotropic/antioxidant work	Anti-inflammatory, not lipids
Main interaction	Bleeding; HIV protease inhibitors	Antiplatelets; thyroid; additive cardiac	Thyroid; reduces propranolol and diltiazem levels
Pregnancy	Food amounts fine; avoid high-dose	Avoid	Contraindicated
Sourcing issue	,	Adulteration with other Terminalia	Critically endangered

Three lessons this teaches about the category

Worth drawing out, because they apply well beyond these three.

1. Early small trials in a field often overstate the effect. Garlic and guggul both followed this pattern, promising early results, disappointing larger ones. This is a general feature of the literature, not bad luck.

2. “Traditional use” and “proven effect” are different claims, and conflating them is the core dishonesty of this market. Guggul’s traditional lipid use is genuine. It is also not supported by the best trial. Both statements are true.

3. The interactions matter more than the efficacy. These herbs are taken by exactly the population on cardiac medication, and guggul reducing propranolol and diltiazem levels, or garlic adding to anticoagulation, is a bigger real-world effect than any benefit claimed. The harm pathway in this category runs through interactions and through delay, not through the herb being useless.

Interactions, the summary table to show your doctor

If you take	Watch for
Warfarin, DOACs, clopidogrel, aspirin	Garlic, arjuna, guggul, all may add to bleeding risk
Propranolol, diltiazem	Guggul reduces their blood levels
Thyroid replacement	Guggul; arjuna reported in animal work
Antihypertensives	Additive effects, monitor blood pressure
Statins	Red yeast rice contains a statin, never combine
HIV protease inhibitors	Garlic reduces levels
Before any surgery	Stop high-dose garlic and all three well in advance; tell the anaesthetist

And the practical instruction: take the actual bottles to your doctor, or photograph the labels. Naming a product is less useful than showing the ingredient panel.

Regulation, why labels differ

A classical Ayurvedic medicine made to a First Schedule text, Arjunarishta, Yograj Guggulu, is licensed under the Drugs and Cosmetics Act by the state AYUSH authority and may carry the indications its text gives.

A food supplement under FSSAI’s nutraceutical route may make no medicinal claims, only authorised nutrient-function claims and traditional-use statements.

And above both, the Drugs and Magic Remedies (Objectionable Advertisements) Act restricts advertising for a schedule of conditions regardless of licence, and heart disease is among the areas this bites hardest.

The commonest violation in this category is a food supplement borrowing a classical text’s cardiac indications. That is not a grey area, and it is routine.

Claims, what we print and what we refuse

What is sayable: traditional-use statements, that arjuna and guggul have long traditional use in Ayurveda, framed clearly as traditional use, plus authorised nutrient-function claims for vitamins and minerals present: thiamine contributes to normal cardiac function; potassium contributes to the maintenance of normal blood pressure; EPA and DHA contribute to normal cardiac function where the product meets the required intake conditions.

What is not sayable: lowers cholesterol, clears arteries, strengthens the heart, prevents heart attack, treats angina or heart failure, or reduces cardiac risk.

What we refuse outright, and have lost enquiries over:

“Blockage clearing” and “avoid bypass” claims. These are the most harmful claims in Indian supplement marketing, they are untrue, they are illegal, and people act on them by postponing angiography and surgery.

Any product positioned as a replacement for, or a reason to reduce, prescribed cardiac medication.

Testimonials referencing recovery from a cardiac event.

And what we require on artwork: a statement to tell your doctor you are taking it, because of the interaction profile above. Almost nobody prints this, and in this category it is the single most useful sentence on the pack.

The honest ranking

If someone with raised cholesterol or cardiac risk asked us what to do:

1. Stop tobacco entirely. 2. Know and treat your blood pressure, glucose and lipids, and take the prescribed medicine. The statin and antihypertensive evidence is among the strongest in medicine. 3. Oil swap, trans fats out, soluble fibre in, sugary drinks gone, walk daily. 4. Weight and waist. 5. Annual influenza vaccination, specifically advised in cardiac disease. 6. And then, if you want, a traditional formulation, with your doctor informed, and knowing the evidence is preliminary.

Our product is sixth, and we would rather say so than sell it as the first.

When to see a doctor

Urgently:

• Chest pain, pressure or heaviness, particularly with sweating, nausea, or radiation to arm, jaw, neck or back
• And in women and people with diabetes, presentation is more often atypical, fatigue, breathlessness, nausea
• Sudden breathlessness, or breathlessness at rest
• Fainting, or near-fainting
• Stroke signs, face drooping, arm weakness, speech difficulty

Soon:

• Before starting any of these three if you take warfarin, a DOAC, clopidogrel, aspirin, propranolol, diltiazem or thyroid replacement
• Before any planned surgery, stop high-dose garlic in advance
• If you take red yeast rice, it contains a statin
• Breathlessness lying flat, or ankle swelling
• Lipids, blood pressure or glucose not checked in the last year
• Family history of early heart disease or sudden death

The short version

1. Three long-standing botanicals, three different reasons the evidence disappoints.
2. Garlic: good trials found no meaningful LDL effect. Early promise did not survive scrutiny.
3. Allicin is unstable, so garlic preparations differ chemically, some trial inconsistency is this.
4. Aged garlic extract contains no allicin at all.
5. Garlic’s most defensible finding is a modest blood pressure reduction, mainly in hypertension.
6. Garlic inhibits platelets, a safety issue, and it reduces HIV protease inhibitor levels.
7. Stop high-dose garlic well before surgery.
8. Arjuna’s classical indication genuinely is cardiac, the positioning is not invented.
9. But there is no adequately powered trial of arjuna for any cardiac outcome.
10. Arjuna bark is adulterated with other Terminalia species, identity testing matters.
11. Guggul’s lipid use is genuinely traditional, and the best randomised trial found no LDL reduction, with LDL slightly rising and rashes occurring.
12. Guggul affects thyroid function.
13. Guggul reduces blood levels of propranolol and diltiazem, a real, under-communicated problem.
14. Guggul is contraindicated in pregnancy.
15. Commiphora wightii is critically endangered, sourcing is an ethical question.
16. Early small trials in this field systematically overstate effects.
17. “Traditional use” and “proven effect” are different claims.
18. The interactions matter more than the efficacy, this population is on cardiac drugs.
19. Take the actual bottles to your doctor.
20. Food supplements cannot borrow a classical text’s indications.
21. “Blockage clearing” and “avoid bypass” are the most harmful claims in this market. Untrue, illegal, and acted upon.
22. Print “tell your doctor you are taking this.” It is the most useful line on the pack.

Composition detail: Cardio 360, arjuna capsule and arjuna heart juice. Related: CoQ10 and statins, कोलेस्ट्रॉल में क्या खाएँ, and licences for Ayurvedic manufacturing.